Search PubMedSearch

Biomedical subjects

E Herskovits

Publications and source records attributed to E Herskovits.

At least 19 recordsLinked to original sources

A hybrid classifier for automated radiologic diagnosis: preliminary results and clinical applications.

We describe the design, implementation, and preliminary evaluation of a computer system to aid clinicians in the interpretation of cranial magnetic-resonance (MR) images. The system classifies normal and pathologic tissues in a test set of MR scans with high accuracy. It also provides a simple, rapid means whereby an unassisted expert may reliably label an image with his best judgment of its histologic composition, yielding a gold-standard image; this step facilitates objective evaluation of classifier performance. This system consists of a preprocessing module; a semiautomatic, reliable procedure for obtaining objective estimates of an expert's opinion of an image's tissue composition; a classification module based on a combination of the maximum-likelihood (ML) classifier and the isodata unsupervised-clustering algorithm; and an evaluation module based on confusion-matrix generation. The algorithms for classifier evaluation and gold-standard acquisition are advances over previous methods. Furthermore, the combination of a clustering algorithm and a statistical classifier provides advantages not found in systems using either method alone.

Algorithms

Comparative study of pentoxifylline vs antiaggregants in patients with transient ischaemic attacks.

Out of 235 patients with recent cerebral transient ischaemic attacks, 208 subjects were available for final evaluation after 6 months' randomised treatment with either pentoxifylline (PTX 1200 mg/day) or a combination (ASAD) of acetylsalicylic acid (ASA, 1050 mg/day) and dipyridamole (D, 150 mg/day). Prevention of TIA, stroke or death attributable to previous events were endpoint criteria. The pentoxifylline group (n = 100) exhibited no recurrent episodes in 86 patients (86%). TIA occurred in 9 patients, stroke in 5 patients and there was 1 death. In the ASAD group (n = 108) no recurrence of ischaemic episodes was recorded in 82 cases (75.9%). TIA occurred in 20 patients, stroke in 6 patients and there were 3 deaths of vascular origin. Side effects were recorded in 4 ASAD and 1 PTX patients. The total rate of recurrence was 14% with PTX as compared to 24.1% with ASAD treatment.

Aged

Development of parkinsonism after transient ischemic attacks.

In order to correlate the influence of cerebrovascular disorders with the appearance of parkinsonism, 115 patients aged between 32 and 84 years (mean = 65) with transient ischemic attacks were followed up for one year. They were treated with platelet antiaggregant drugs. None of them received neuroleptics, calcium antagonists or other drugs known to induce parkinsonism. During the study, 8 patients (mean = 75 years) developed parkinsonism, bilateral in all but one, who remarkably enough was the only case responding to L-dopa treatment. On comparing recorded with expected incidence, our series showed significantly greater values. Our findings suggest that cerebrovascular disorders are factors contributing to parkinsonism in the elderly.

Adult

[Specular bilateral lenticular hematomas].

A 49-year-old right-handed hypertensive female developed two consecutive putaminal hemorrhages in the left and right hemispheres within one month. Recurrent specular hypertensive hematomas are rare, even though the underlying pathological changes in the arterial wall occur bilaterally. This may be explained by the spontaneous decrease in blood pressure occurring in patients after an acute stroke. In this patient, a new abrupt increase in blood pressure may account for the second hemorrhage. While lowering the blood pressure during an acute stroke may be in principle unadvisable, it seems reasonable to prevent a new increase in blood pressure with adequate therapy.

Cerebral Hemorrhage

Hereditary essential tremor in Buenos Aires (Argentina).

A descriptive trial of essential tremor in Buenos Aires city is proposed. It may be considered as the first one like this in Latin America. During a 15 year period, sixteen families with essential tremor diagnosis have been examined, making a total of 39 patients (20 males and 19 females). The disease was basically studied from its semiological, clinico-evolutive and therapeutical view point, following a protocol. Our results indicate -- a. The clinico-evolutive characteristics: its frequency (according to race, sex, social status, age of beginning and physiopathological type), morbidity and mortality, evolution, prognosis, triggering factors, longevity and multiparity. b. The different treatment given to our patients with discussion of their pharmacokinetic and pharmacodynamic basis and evaluation of the best responses. In this matter, it is concluded that both primidone (750 mg/daily) and/or propranolol (160-240 mg/daily) are undeniably the drugs of first choice for the treatment of this disease. A comparison of the clinico-therapeutic features of this tremor in Buenos Aires and other cities is done. The study of this syndrome in Buenos Aires does not give different results from those obtained in Europe and USA.

Argentina

Preventive treatment of cerebral transient ischemia: comparative randomized trial of pentoxifylline versus conventional antiaggregants.

A comparative study of the prevention of recurrences of cerebral transient ischemic attacks during a 6-month observation period was conducted in 73 patients treated with a combination of acetylsalicylic acid and dipyridamole (ASAD, 1,050 mg + 150 mg/day) and in 65 patients treated with pentoxifylline (PTX 1,200 mg/day, Trental 400 t.d.s.). The patients were randomly assigned to the treatments. Risk factor analysis showed high prevalence of arterial hypertension, hyperlipidemia and smoking in these patients. The two groups were matched in terms of age, sex, blood pressure and site of TIA origin (carotid 63% in the ASAD, 65% in the PTX group). 23 ASAD patients and 9 PTX patients suffered a recurrence. There were 4 nonfatal stroke events with ASAD and 2 with PTX. 80 recurrent TIAs were recorded in 19 ASAD patients compared with 19 such episodes in 9 PTX subjects. The morbidity rates (life table analysis) were significantly lower (p less than 0.05) in the PTX group. The results of the study point to a preventive effect of PTX in terms of the reduction in TIA recurrences.

Aged

Randomised trial of pentoxifylline versus acetylsalicylic acid plus dipyridamole in preventing transient ischaemic attacks.

In a multicentre trial to compare the ability of a combination of acetylsalicylic acid and dipyridamole (1050 mg + 150 mg/day, group A) to prevent recurrence of transient ischaemic attacks (TIA) with that of pentoxifylline (1200 mg/day, group B), 36 patients received the combination and 30 pentoxifylline. There was no statistically significant difference between the groups as regards age, sex, blood pressure, site of origin of TIA, and incidence of other risk factors. The incidence of recurrent TIAs during 1 year of follow-up was 28% in group A and 10% in group B; this difference was significant (p less than 0.05). The incidence of permanent strokes was similar in the two groups but distinctly lower (4.5%) than that usually reported after untreated TIA.

Aspirin

[Considerations on low pressure hydrocephalus].

The physiopathological conditions of the normal pressure hydrocephalus syndrome are analysed. Within a group of 21 patients with clinical sintomathology pertaining this entity, only were 10 selected with a clinical, radiological and cisternografic indubitable diagnosis. It has been noticed that in spite of the stricked selection only a 50% of them have been beneficed by the application of a low pressure valve. Then, the hypothesis that the disease is a multicausal syndrome appears, which by an identical physiopathologic process produces or exhibits a similar clinical, radiological and cisternographic picture. Only those patients on whom the mechanical problem is solved would be beneficed by neurosurgery.

Cerebrospinal Fluid

[Opsoclonus].

Explore the source record for details and available documents.

Adolescent